Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Yao-Xian Yue"'
Autor:
Xiao-Jun Ding, Hong-Yan Li, Huaiping Wang, Xue-Hua Zhang, Min Song, Xiao-Han Jiang, Xu Zhang, Yao-Xian Yue, Xiao-Hong Li
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectiveThe homeostasis of the immune system is influenced by the gut microbiota. Previous studies have reported dysbiosis in the gut microbiota of myasthenia gravis (MG) patients. To investigate potential alterations in gut microbiota and metabolit
Externí odkaz:
https://doaj.org/article/ee0f5e84457c44ba9b9eb9c1f8fadad6
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundVaccination remains the most effective measure to prevent SARS-CoV-2 infection and worse outcomes. However, many myasthenia gravis (MG) patients are hesitant to receive vaccine due to fear of worsening.MethodsMG patients were consecutively
Externí odkaz:
https://doaj.org/article/7997f74b41c245448eccca8a01fc03a4
Autor:
Hong-Yan Li, Ping Jiang, Yanchen Xie, Bing Liang, Ling Li, Cuiping Zhao, Yao-Xian Yue, Hai-Feng Li
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundThe absolute change in the severity score between the baseline and pre-specified time frame (absolute criterion) was recommended as a criterion for myasthenia gravis (MG) treatment response. But heterogeneity of disease severity might dilut
Externí odkaz:
https://doaj.org/article/436ed40a229d4e5ba4bbaacdf1660e60
Autor:
Ping Jiang, Jie Li, Hong-Yan Li, Bin Zhang, Yao-Xian Yue, Su-Yun Wang, Xi-Cun Zi, Shuang-Shuang Liu, Yi-Fan Li, Li-Dong Jiao, Hai-Feng Li
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionMinimal manifestation (MM) or better was recommended as the treatment goal for myasthenia gravis (MG). The sustainability of this status has not been described quantitatively in patients who had attained or are close to it.MethodsPatients
Externí odkaz:
https://doaj.org/article/2d29393dd68740f6bf671426ac9cbe63
Autor:
Ji-Lan Han, Yao-Xian Yue, Xiang Gao, Yan-Chen Xie, Hong-Jun Hao, Hong-Yan Li, Xiao-Long Yu, Jie Li, Rui-Sheng Duan, Hai-Feng Li
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Myasthenia gravis (MG) is an autoimmune disease in which antibodies bind to acetylcholine receptors (AChR) or other functional molecules in the postsynaptic membrane at the neuromuscular junction. Vitamin D (VD) has a number of pluripotent effects, w
Externí odkaz:
https://doaj.org/article/6244eff16ba9400ca8b51c02facdae7c
Autor:
Xiao-long YU, Bing LIANG, Yao-xian YUE, Xu ZHANG, Yan-chen XIE, Xian-jun ZHANG, Chuan-kai GU, Min SONG, Xiao-jun DING, Hong-jun HAO, Hai-feng LI
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 16, Iss 10, Pp 670-677 (2016)
Objective To explore the association of three single nucleotide polymorphisms (SNPs; rs228942, rs228941 and rs743777) in interleukin-2 receptor β subunit (IL-2Rβ) gene with the susceptibility and severity of myasthenia gravis (MG). Methods There we
Externí odkaz:
https://doaj.org/article/7184f0225da44266a2f37095d9afe43a
Autor:
Ping Jiang, Yao-Xian Yue, Yu Hong, Yanchen Xie, Xiang Gao, Chuan-Kai Gu, Hong-Jun Hao, Yue Qin, Xiao-Jun Ding, Min Song, Hai-Feng Li, Xu Zhang
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
Interleukin-4 (IL-4) is a potent growth and differentiation factor for B cells which play a vital role in the pathogenesis of myasthenia gravis (MG). IL-4 exerts its function by binding to three types of IL-4 receptor (IL-4R) complexes. IL-4Rα is th
Externí odkaz:
https://doaj.org/article/f95ffceebf7f4400b3f46de84e299f31
Autor:
Kai, Shao, Yao-Xian, Yue, Li-Ming, Zhao, Hong-Jun, Hao, Xiao-Jun, Ding, Ping, Jiang, Chuan-Zhu, Yan, Hai-Feng, Li
Publikováno v:
Clinica Chimica Acta. 533:122-130
This study aims to establish an optimization procedure to define the cut-offs of quantitative assays for acetylcholine receptor antibody (AChRAb), evaluate their diagnostic performance in myasthenia gravis (MG), and explore the association with clini
Autor:
Yao-Xian Yue, Qi Wang, Hai-Feng Li, Xian-Jun Zhang, Hong-Jun Hao, Xiang Gao, Zhe Gao, Bing Liang, Yanchen Xie, Gao-Mei Cai
Publikováno v:
Journal of Clinical Neuroscience. 69:31-37
Abnormal CTLA-4 expression is involved in the development of myasthenia gravis (MG), and serum CTLA-4 levels are positively correlated with serum anti-AChR antibody concentration, which might be related with the severity of MG. Polymorphism in CTLA-4
Autor:
Shougang Guo, Hai-Feng Li, Yao-Xian Yue, Tian-Ping Tang, Chuan-Kai Gu, Xiang Gao, Yanchen Xie, Xiao-Jun Ding, Min Song, Hong-Jun Hao, Hong-Yan Li
Publikováno v:
Journal of neuroimmunology. 353
Complement component 3 (C3) had been proved to be involved in the pathogenesis and exacerbation of both myasthenia gravis (MG) patients and experimental autoimmune myasthenia gravis (EAMG) models. We evaluated the underlying association between five